Skip to content
healthcare.dev

lamivudine

NDC 31722-001, lamivudine, tablet, film coated, from Camber Pharmaceuticals, Inc..

Product NDC
31722-001
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211306
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE100 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
31722-001-023172200010220 BLISTER PACK in 1 CARTON (31722-001-02) / 10 TABLET, FILM COATED in 1 BLISTER PACK
31722-001-603172200016060 TABLET, FILM COATED in 1 BOTTLE (31722-001-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e90671c6-7fff-48f4-8898-29f02d049c8b

Use it

Look up 31722-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.